Ownership Summary
According to SEC filings for the period ending September 2025, PureTech Health plc (NASDAQ:PRTC) is held by 7 institutional firms.
- The collective stake of institutional investors in PureTech Health moved to 47.7% in September 2025, a shift up from the 1.2% reported for June 2025.
- On a quarter-over-quarter basis, institutional holdings shifted by 17042.26%, with a year-over-year an increase of 40.00% in the count of filers.
- Among the 7 institutional holders of PureTech Health, 3 added to their stakes while 1 trimmed their positions and 3 held steady.
- The total number of shares held by institutions in PureTech Health increased to 14.21Mn as of September 2025, a net change of up by 14.13Mn shares quarter on quarter, and up 14.18Mn shares year over year.
- As of September 30, 2025, LANSDOWNE PARTNERS (UK) LLP held PureTech Health's largest shareholding position with over 14.11Mn shares, representing 47.32% of total outstanding shares.
- Among the most significant buyers of PureTech Health during September 2025 were LANSDOWNE PARTNERS (UK) LLP (14.11Mn), Pentwater Capital Management LP (25.00K), SBI Securities Co., Ltd. (2).
- Leading sellers of PureTech Health stock in September 2025 included MILLENNIUM MANAGEMENT LLC (6.02K).
- The top 7 institutional holders of PureTech Health for the quarter ending September 2025 included LANSDOWNE PARTNERS (UK) LLP (14.11Mn), Pentwater Capital Management LP (75.00K), MILLENNIUM MANAGEMENT LLC (17.84K), DIADEMA PARTNERS LP (7.32K), Persistent Asset Partners Ltd (1.69K), UBS Group AG (20), SBI Securities Co., Ltd. (2).